Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study

被引：0
|
作者：
Nagai, T. [1 ]
Nakanishi, N. [1 ]
Yamashita, Y. [2 ]
Muraoka, N. [3 ]
Umetsu, M. [4 ]
Nishimoto, Y. [5 ]
Takada, T. [6 ]
Ogihara, Y. [7 ]
Nishikawa, T. [7 ]
Ikeda, N. [8 ]
Otsui, K. [9 ]
Sueta, D. [10 ]
Tsubata, Y. [11 ]
Shoji, M. [12 ]
Matoba, S. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Kyoto, Japan
[2] Kyoto Univ, Cardiovasc Med, Kyoto, Japan
[3] Shizuoka Canc Ctr, Cardiol, Shizuoka, Japan
[4] Tohoku Univ Hosp, Vasc Surg, Sendai, Miyagi, Japan
[5] Osaka Gen Med Ctr, Cardiol, Osaka, Japan
[6] Tokyo Womens Med Univ, Cardiol, Tokyo, Japan
[7] Mie Univ, Cardiol & Nephrol, Grad Sch Med, Tsu, Mie, Japan
[8] Toho Univ, Cardiovasc Med, Ohashi Med Ctr, Tokyo, Japan
[9] Kobe Univ, Internal Med, Kobe, Hyogo, Japan
[10] Kumamoto Univ, Cardiovasc Med, Kumamoto, Japan
[11] Shimane Univ, Fac Med, Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
[12] Natl Canc Ctr, Cardiovasc Med, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial
    Girardi, Laura
    Mallick, Ranjeeta
    Wang, Tzu-Fei
    Carrier, Marc
    Auer, Rebecca
    EJSO, 2025, 51 (05):
  • [32] Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial
    Wang, Tzu-Fei
    Mallick, Ranjeeta
    Noureldin, Abdelrahman
    Pecarskie, Amanda
    Carrier, Marc
    Auer, Rebecca
    THROMBOSIS RESEARCH, 2024, 242
  • [33] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Ruediger B. Mueller
    Hendrik Schulze-Koops
    Daniel E. Furst
    Stanley B.  Cohen
    Kenneth Kwok
    Lisy Wang
    Tim Killeen
    Johannes von Kempis
    Clinical Rheumatology, 2022, 41 : 1045 - 1055
  • [34] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Mueller, Ruediger B.
    Schulze-Koops, Hendrik
    Furst, Daniel E.
    Cohen, Stanley B.
    Kwok, Kenneth
    Wang, Lisy
    Killeen, Tim
    von Kempis, Johannes
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1045 - 1055
  • [35] Efficacy and Safety of Extended Duration Postoperative Thromboprophylaxis with Low-Molecular-Weight-Heparin Among Subgroups of Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the Periop-01 Trial
    Girardi, Laura
    Auer, Rebecca
    Mallick, Ranjeeta
    Wang, Tzu-Fei
    Carrier, Marc
    BLOOD, 2023, 142
  • [36] Safety and impact in cardio vascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
    Athyros, Vassilios G.
    Giouleme, Olga
    Ganotakis, Emmanouel S.
    Elisaf, Moses
    Tziomalos, Konstantinos
    Vassiliadis, Themistoklis
    Liberopoulos, Evangelos N.
    Theocharidou, Eleni
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (05) : 796 - 805
  • [37] Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis
    Gladman, Dafna D.
    Nash, Peter
    Mease, Philip J.
    Fitzgerald, Oliver
    Duench, Stephanie
    Cadatal, Mary Jane
    Masri, Karim R.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [38] Efficacy and Safety of Tofacitinib in an Open-Label, Long-Term Extension Study in Patients with Psoriatic Arthritis Who Received Adalimumab or Tofacitinib in a Phase 3 Randomized Controlled Study: A Post Hoc Analysis
    Gladman, Dafna
    Nash, Peter
    Mease, Philip J.
    FitzGerald, Oliver
    Masri, Karim R.
    Duench, Stephanie
    Jane Cadatal, Mary
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2798 - 2801
  • [39] Factors influencing patient's perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study
    Debourdeau, P.
    Arvers, P.
    Hij, A.
    Bennani, H.
    Desauw, C.
    Falvo, N.
    Ghiringhelli, F.
    Hamade, A.
    Vedrine, L.
    Farge, D.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 287 - 293
  • [40] Factors influencing patient’s perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study
    P. Debourdeau
    P. Arvers
    A. Hij
    H. Bennani
    C. Desauw
    N. Falvo
    F. Ghiringhelli
    A. Hamadé
    L. Vedrine
    D. Farge
    Supportive Care in Cancer, 2020, 28 : 287 - 293
12345